John Menditto | Vice President-Investor Relations and Corporate Communications |
David Mazzo | President and Chief Executive Officer |
James Nisco | Vice President-Finance and Treasury |
Kristen Buck | Executive Vice President-Research and Development and Chief Medical Officer |
Kumar Raja | Brookline Capital Markets |
Lander Ron | H.C. Wainwright |
Pete Enderlin | MAZ Partners |
Welcome to the Caladrius Biosciences Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.
Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this call is being recorded today, Tuesday, March 22, 2022. I’ll now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communications at Caladrius.